Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 4,826–4,850 of 27,380 studies, newest first · page 194 of 1096.

March 2025 25

  1. 2025-03-28
  2. 2025-03-28

    Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials

    ✓ Peer-reviewed Biomarkers Nature Aging

    Key finding: In a head-to-head comparison study including nine cohorts and 1,474 individuals, we show that plasma p-tau217 and medial temporal lobe tau-PET signal display similar associations with cognitive decline on a global cognitive composite test (R 2 PET = 0.34 versus R 2 plasma = 0.33, P difference = 0.653) and with progression to mild cognitive impairment (hazard ratio (HR) PET = 1.61 (1.48-1.76) versus HR plasma = 1.57 (1.43-1.72), P difference = 0.322). +1 more finding

  3. 2025-03-27

    The Silent Saboteur: How Mitochondria Shape the Long-Term Fate of the Injured Brain

    ⚠ Preprint — not yet peer-reviewed Biomarkers bioRxiv : the preprint server for biology

    Key finding: Comparative transcriptomic analysis at 6 and 48 hours post-injury revealed conserved mitochondrial impairments across excitatory neurons, interneurons, astrocytes, and microglia. +1 more finding

    Scored 22 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  4. 2025-03-27

    Plasma biomarker trajectories: Impact of AD genetic risk and clinical progression

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: Compared to non-carriers, APOE ε4 carriers had lower Aβ42/Aβ40 and greater longitudinal increases in p-tau181 and GFAP; in contrast, the AD-PRS (excluding the APOE region) was associated with greater declines in Aβ42/Aβ40 among APOE ε4 non-carriers. +3 more findings

  5. 2025-03-27

    Systematic review of differentially abundant proteins in people with Lewy body dementia

    ✓ Peer-reviewed Inflammation and the immune system Acta neuropsychiatrica

    Key finding: Our meta-analyses confirmed significantly lower CSF TAU levels in DLB and CSF SYUA levels in PDD, when compared to Alzheimer's disease. +3 more findings

  6. 2025-03-27

    α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies

    ✓ Peer-reviewed Disease mechanisms Frontiers in Neuroscience

    Key finding: These findings advocate for integrated therapeutic strategies targeting protein cross-seeding and proteostatic disruption while preserving physiological roles.

  7. 2025-03-27

    Cerebral Small Vessel Disease: Therapeutic Approaches Targeting Neuroinflammation, Oxidative Stress, and Endothelial Dysfunction

    ✓ Peer-reviewed Inflammation and the immune system Current Issues in Molecular Biology

    Key finding: As there is currently no curative therapy for cSVD, prevention or delay of cSVD remains of particular importance to preserve quality of life for as long as possible. +4 more findings

  8. 2025-03-27

    Choroidal Neovascularization Is Suppressed With Activation of TREM2 in Mononuclear Phagocytes—Brief Report

    ✓ Peer-reviewed Risk genes beyond APOE Arteriosclerosis Thrombosis and Vascular Biology

    Key finding: We found that pharmacological activation of TREM2 suppressed laser-induced choroidal neovessel formation. +3 more findings

  9. 2025-03-27
  10. 2025-03-27

    Preliminary efficacy of an online intervention based on Acceptance and Commitment Therapy for family caregivers of people with dementia: a feasibility study

    ✓ Peer-reviewed Caregiving Cognitive Behaviour Therapy

    Key finding: Linear mixed-effect models based on a complete-case analysis showed significant changes in depressive symptoms (mean difference: −3.34, d = −0.78). +3 more findings

  11. 2025-03-27

    Identifying and Addressing Unmet Needs in Dementia: The Role of Care Access and Psychosocial Support

    ✓ Peer-reviewed Caregiving International Journal of Geriatric Psychiatry

    Key finding: People with dementia were on average 80.6 years old, mostly female (56%) and mildly to moderately cognitively impaired (85%). 98.6% of the participants had at least one need, of which just over a third (36.5%) were rated as met and just under two-thirds (63.5%) as unmet. +4 more findings

  12. 2025-03-27

    Donanemab: Appropriate use recommendations

    ✓ Peer-reviewed Treatments The journal of prevention of Alzheimer's disease

    Key finding: Appropriate Use Recommendations (AUR) were developed to guide the implementation of donanemab in real-world practice, prioritizing safety considerations and opportunity for effectiveness. +3 more findings

  13. 2025-03-27

    Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research

    ✓ Peer-reviewed TREM2 and immune genetics Molecular neurodegeneration

    Key finding: These immune cells undergo metabolic reprogramming in response to AD-related pathology, with key genes such as TREM2, APOE, and HIF-1α orchestrating these processes. +3 more findings

  14. 2025-03-27
  15. 2025-03-26
  16. 2025-03-26

    Blood-based biomarkers of Alzheimer’s disease and incident dementia in the community

    ✓ Peer-reviewed How common it is Nature Medicine

    Key finding: In multi-adjusted Cox regression models, elevated baseline levels of p-tau181, p-tau217, NfL, and GFAP were associated with a significantly increased hazard for all-cause and AD dementia, displaying a non-linear dose-response relationship. +2 more findings

  17. 2025-03-26
  18. 2025-03-26

    Nexus Between Exposure to Natural Outdoor Environments and Cognitive Competence among Older Adults in China

    ✓ Peer-reviewed Risk factors Annals of the American Association of Geographers

    Key finding: Using regression methods and stratified analysis, we demonstrate that there exists a positive relation between access to blue-green spaces and cognitive competence among older Chinese adults. +4 more findings

  19. 2025-03-26

    Associations between plasma complement C1q and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact adults: The CABLE study

    ✓ Peer-reviewed Tau biomarkers Journal of Alzheimer's disease : JAD

    Key finding: However, the relationships between C1q and the major pathological challenges, including amyloid-β (Aβ) and tau deposition, remain undetermined in the preclinical AD phase. +1 more finding

  20. 2025-03-25

    Current Technological Advances in Dysphagia Screening: Systematic Scoping Review

    ✓ Peer-reviewed Clinical safety Journal of Medical Internet Research

    Key finding: This review included 24 studies involving 2979 participants (1717 with dysphagia and 1262 controls). +4 more findings

  21. 2025-03-25

    The MIND diet, cognitive function, and well-being among healthy adults at midlife: a randomised feasibility trial

    ✓ Peer-reviewed Prevention trials BMC Nutrition

    Key finding: A repeated measures ANOVA showed that in comparison to the control group, both intervention groups significantly improved mood, quality of life, MIND diet score and all COM-B components at follow-up (p < 0.05). +4 more findings

  22. 2025-03-25

    Potential targets of microglia in the treatment of neurodegenerative diseases: Mechanism and therapeutic implications

    ✓ Peer-reviewed Inflammation and the immune system Neural Regeneration Research

    Key finding: Furthermore, dysfunctional and hyperactivated microglia initiate mitochondrial autophagy, oxidative stress, and pathological protein accumulation, ending with neuroinflammation that exacerbates damage to dopaminergic neurons and contributes significantly to the pathology of neurodegenerative disorder. +1 more finding

  23. 2025-03-25

    Cerebellar dysfunction in frontotemporal dementia: intra-cerebellar pathology and cerebellar network degeneration

    ✓ Peer-reviewed Lewy body dementia Journal of Neurology

    Key finding: Radial diffusivity analyses detected impaired bilateral cerebello-frontal, cerebello-parietal, and cerebello-temporal connectivity in all study groups along the ALS-FTD spectrum. +4 more findings

  24. 2025-03-25

    Crucial role of microglia-mediated myelin sheath damage in vascular dementia: Antecedents and consequences

    ✓ Peer-reviewed Lewy body dementia Neural Regeneration Research

    Key finding: Chronic cerebral hypoperfusion can lead to neuronal necrosis, trigger inflammatory responses, promote white matter damage, and ultimately result in cognitive impairment. +1 more finding

  25. 2025-03-25

    Type 2 diabetes and late-onset Alzheimer’s disease and related dementia: A longitudinal cohort study integrating polygenic risk score

    ✓ Peer-reviewed How common it is Journal of Alzheimer s Disease

    Key finding: T2DM is one of the strong risk factors of ADRD but genetic T2DM effect does not contribute to ADRD risk. +2 more findings

Browse the library by subject, with the full score breakdown →